Covered recipient · General Payments record
CESAR BRICENO
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2019–2024
$65,428.92
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $28,013.75 | 12 |
| Travel and Lodging | $14,797.63 | 11 |
| Food and Beverage | $984.56 | 6 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| F. Hoffmann-La Roche AG | $15,416.36 | 5 |
| Genentech USA, Inc. | $14,430.32 | 10 |
| Amgen Inc. | $8,244.26 | 7 |
| Genentech, Inc. | $5,705.00 | 7 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $96.52 | 04/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1111536365 | CMS |
| Amgen Inc. | $4,000.00 | 04/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1111536367 | CMS |
| Amgen Inc. | $1,437.02 | 04/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1111536369 | CMS |
| Amgen Inc. | $62.56 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111536371 | CMS |
| Amgen Inc. | $585.15 | 04/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1111536361 | CMS |
| Amgen Inc. | $2,000.00 | 04/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1111536363 | CMS |
| Amgen Inc. | $63.01 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111536373 | CMS |
| F. Hoffmann-La Roche AG | $4,878.75 | 03/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1132985515 | CMS |
| F. Hoffmann-La Roche AG | $176.01 | 03/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132985519 | CMS |
| F. Hoffmann-La Roche AG | $9,857.73 | 03/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132985523 | CMS |
| F. Hoffmann-La Roche AG | $177.03 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132985527 | CMS |
| F. Hoffmann-La Roche AG | $326.84 | 03/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132985531 | CMS |
| Genentech USA, Inc. | $268.52 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132985490 | CMS |
| Genentech USA, Inc. | $80.42 | 03/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132985495 | CMS |
| Genentech USA, Inc. | $19.90 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132985499 | CMS |
| Genentech USA, Inc. | $6,200.00 | 03/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1132985503 | CMS |
| Genentech USA, Inc. | $471.30 | 03/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132985507 | CMS |
| Genentech USA, Inc. | $825.08 | 03/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132985511 | CMS |
| Genentech USA, Inc. | $393.54 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132985535 | CMS |
| Genentech USA, Inc. | $365.11 | 10/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132985539 | CMS |
| Genentech USA, Inc. | $576.45 | 10/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132985543 | CMS |
| Genentech USA, Inc. | $5,230.00 | 10/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1132985547 | CMS |
| Genentech, Inc. | $690.00 | 04/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1132985462 | CMS |
| Genentech, Inc. | $230.00 | 07/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1132985470 | CMS |
| Genentech, Inc. | $345.00 | 08/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1132985466 | CMS |
| Genentech, Inc. | $690.00 | 09/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1132985474 | CMS |
| Genentech, Inc. | $1,380.00 | 10/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1132985478 | CMS |
| Genentech, Inc. | $690.00 | 10/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1132985482 | CMS |
| Genentech, Inc. | $1,680.00 | 11/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1132985486 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.